Silco Pharmaceuticals Limited (DSE:SILCOPHL)
Bangladesh · Delayed Price · Currency is BDT 20.70
-0.70 (-3.27%)
At close: Jul 26, 2026
Silco Pharmaceuticals Financials Overview
Financials in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Revenue Revenue Growth | 408.71 | 431.54 | 410.1 | 464.7 | 559.47 | 601.06 |
Revenue Growth | -4.65% | 5.23% | -11.75% | -16.94% | -6.92% | -18.07% |
Gross Profit Gross Profit Growth | 139.31 | 153.04 | 131.85 | 145.93 | 186.75 | 167.76 |
Operating Income Operating Income Growth | 67 | 78.26 | 59.17 | 67.18 | 97.48 | 79.39 |
Net Income Net Income Growth | 34.23 | 42.65 | 45.88 | 69.22 | 84.45 | 84.65 |
Earnings Per Share EPS Growth | 0.33 | 0.41 | 0.44 | 0.67 | 0.81 | 0.82 |
EPS Growth | -26.71% | -7.04% | -33.72% | -18.03% | -0.23% | 1.77% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Cash & Investments Cash & Investments Growth | 28.6 | 26.26 | 30.47 | 49.73 | 64.63 | 72.44 |
Total Debt Total Debt Growth | 1.29 | 4.99 | 9.57 | - | 4.11 | 7.89 |
Net Cash (Debt) Net Cash Growth | 27.31 | 21.27 | 20.9 | 49.73 | 60.51 | 64.56 |
Net Cash Growth | 47.06% | 1.76% | -57.97% | -17.82% | -6.26% | -74.97% |
Net Cash Per Share Net Cash Per Share Growth | 0.26 | 0.20 | 0.20 | 0.48 | 0.58 | 0.62 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 73.19 | 77.3 | 84.31 | 180.48 | 169.08 | 257.21 |
Capital Expenditures CapEx Growth | -55.98 | -69.76 | -84.26 | -181.95 | -106.13 | -376.43 |
Free Cash Flow Free Cash Flow Growth | 17.21 | 7.54 | 0.05 | -1.47 | 62.95 | -119.22 |
Free Cash Flow Growth | - | 13818.79% | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Gross Margin | 34.09% | 35.46% | 32.15% | 31.40% | 33.38% | 27.91% |
Operating Margin | 16.39% | 18.14% | 14.43% | 14.46% | 17.42% | 13.21% |
Pretax Margin | 16.43% | 18.08% | 14.47% | 19.20% | 19.48% | 14.91% |
Profit Margin | 8.37% | 9.88% | 11.19% | 14.90% | 15.10% | 14.08% |
FCF Margin | 4.21% | 1.75% | 0.01% | -0.32% | 11.25% | -19.84% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 27, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.110 | 0.110 | 0.100 | 0.300 | 0.500 | 1.000 |
Dividend Per Share Growth | 10.00% | 10.00% | -66.67% | -40.00% | -50.00% | 0% |
Dividend Yield | 0.51% | 0.75% | 0.60% | 1.26% | 1.99% | 4.18% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 27, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
PE Ratio | 62.56 | 36.02 | 38.24 | 36.59 | 32.45 | 32.01 |
P/FCF Ratio | 124.83 | 203.70 | 32375.63 | - | 43.53 | - |
PS Ratio | 5.26 | 3.56 | 4.28 | 5.45 | 4.90 | 4.51 |